Anti-wrinkling agent formulated in dermal inflammatory response modulators (DIRMs): Update

The company is seeking a marketing partner, and commercialization is expected in

Read the full 124 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE